ANAB
AnaptysBio·NASDAQ
--
--(--)
--
--(--)
ANAB fundamentals
AnaptysBio (ANAB) released its earnings on Aug 6, 2025: revenue was 22.26M (YoY +102.93%), beat estimates; EPS was -1.34 (YoY +21.64%), beat estimates.
Revenue / YoY
22.26M
+102.93%
EPS / YoY
-1.34
+21.64%
Report date
Aug 6, 2025
EPS
Actual | -0.3 | -0.79 | -0.87 | 1.2 | -0.66 | -0.02 | -0.24 | -1.18 | -1.31 | -1.15 | -1.18 | -0.93 | -1.58 | -1.5 | -1.41 | -1.59 | -1.64 | -1.71 | -1.14 | -0.72 | -1.28 | -1.34 | ||||||||
Forecast | -0.6275 | -0.75 | -0.7217 | 1.9425 | -0.6883 | -0.1028 | -0.8503 | -0.99 | -0.9949 | -0.982 | -0.6221 | -0.957 | -1.0321 | -1.6954 | -1.777 | -1.6007 | -1.5663 | -1.0408 | -1.6469 | -1.6194 | -1.253 | -1.5508 | ||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +52.19% | -5.33% | -20.55% | -38.22% | +4.11% | +80.54% | +71.77% | -19.19% | -31.67% | -17.11% | -89.68% | +2.82% | -53.09% | +11.53% | +20.65% | +0.67% | -4.71% | -64.30% | +30.78% | +55.54% | -2.15% | +13.59% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | 15.00M | 0 | 0 | 60.00M | 11.25M | 30.03M | 20.89M | 1.01M | 970.00K | 1.22M | 1.29M | 6.81M | 1.37M | 3.46M | 3.32M | 9.01M | 7.18M | 10.97M | 30.02M | 43.11M | 27.77M | 22.26M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | 7.71M | 2.32M | 2.00M | 80.00M | 9.39M | 28.88M | 6.65M | 976.00K | 5.05M | 5.30M | 13.43M | 5.78M | 2.90M | 2.68M | 2.29M | 3.79M | 4.00M | 22.76M | 8.21M | 7.78M | 15.27M | 11.68M |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +94.59% | -100.00% | -100.00% | -25.00% | +19.79% | +3.96% | +213.94% | +3.59% | -80.81% | -77.04% | -90.37% | +17.71% | -52.56% | +28.90% | +44.98% | +137.89% | +79.43% | -51.79% | +265.83% | +453.91% | +81.82% | +90.54% |
Earnings Call
You can ask Aime
What does AnaptysBio do and what are its main business segments?What were the key takeaways from AnaptysBio’s earnings call?What is AnaptysBio's gross profit margin?What is AnaptysBio's latest dividend and current dividend yield?What guidance did AnaptysBio's management provide for the next earnings period?What factors drove the changes in AnaptysBio's revenue and profit?What were the key takeaways from AnaptysBio's earnings call?What is the market's earnings forecast for AnaptysBio next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
